Madrigal Pharmaceuticals Aktie
256,00
EUR
-3,90
EUR
-1,50
%
298,42
USD
-0,49
USD
-0,16
%
Werbung
Madrigal Pharmaceuticals Aktie Analyse
10.06.19 | Madrigal Pharmaceuticals Buy | B. Riley FBR | |
28.02.19 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
14.12.18 | Madrigal Pharmaceuticals Outperform | Wolfe Research | |
01.06.18 | Madrigal Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
01.06.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
30.01.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
06.12.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
29.11.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
Werbung
|
Werbung
Werbung